That really is some dark arts there Money! Last time I saw bulk action like that, the share I was in had a takeover! Optimistic either way and looking forward to what news awaits us next!
Totally agree Money. I’m more than happy to see the shares trading at this level as long as they transfer from multiple weak hands, to a few strong hands. Eric did say Q2 is when he expects things to get moving with the FDA, any day now :)
It looks like quite a major event! Would be lovely for there to be a major announcement from Vera. Both US patents are now at the 3 year mark, so it would be amazing if they were both approved to coincide with the Rochester conference!
I don’t think the main bulky trades towards the end of the day were sells and were actually buys and some weak hands fell for the bait (again) in letting panic selling set in. Most of us are here for the main event (buy out), so whatever keeps people busy in the meantime, will be what it will be :)
Yes with there set to be more people aged over 65 than 12, there is a massive market for this to become the new flu jab and the likes of Moderna and AZ must be scrambling to find replacement products for their Covid jabs.
The 2 nr 600’s looked like isa transfers to me as well outside of the margin. Either way, volume over this week is certainly exciting! Even better, as yet another big gene / organ therapy pharma has been snapped up today for $1.06bn!
https://www.fiercepharma.com/pharma/asahi-kasei-puts-106b-offer-tarpeyo-maker-calliditas
Yeah it was because the company listed on the US markets that it spiked. The company has come on leaps and bounds since then, and if they get US medical trial approval, hopefully the company will be exposed to a whole new market of investors!
When you think about Genflow bagging the past month under radar, imagine what it will do with some serious news:
- 2 patents could be approved any day
- US FDA submission due
- Non-dilutive grant money due imminently
- Pipelines progressing
- Collaborative partnerships growing
- Early stage pharma’s in the longevity sector getting snapped up for hundreds of millions to billions
- Entrepreneurs like Jeff Bezo’s investing Billions in their own longevity ventures so a cheap acquisition target in comparison
To me, there are no limitations with how far the team could go!